sang et organes humains – Difficultés récurrentes rencontrées par l'EFS, le LFB et l'ensemble de la filiè

This written question addresses recurring difficulties faced by the French Blood Establishment (EFS) and the LFB (a biopharmaceutical company) in the human blood and organs sector. It seeks to understand the root causes of these issues. The question highlights potential impacts on the availability and safety of blood and organ donations, affecting patients and the healthcare system in France.